Free Trial

Electromed Q1 2024 Earnings Report

Electromed logo
$29.58 +0.93 (+3.25%)
(As of 01:10 PM ET)

Electromed EPS Results

Actual EPS
$0.02
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Electromed Revenue Results

Actual Revenue
$12.32 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Electromed Announcement Details

Quarter
Q1 2024
Time
N/A

Conference Call Resources

Conference Call Audio

A.I. Trading System Helps Some Traders Pocket $1,100 per DAY! (Ad)

What if I told you 60 seconds a day could completely change your life?

This AI-powered trading system finds high-probability option trades in less than 60 seconds a day

Click HERE to access this powerful AI Trading System

Electromed Earnings Headlines

Please don’t take this warning lightly…
Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most significant market event of my 47-year career..." He says that when this event comes crashing down on the stock market in the coming months… millions of investors will be taken by surprise.
Electromed, Inc. (ELMD) Q1 2025 Earnings Call Transcript
The Stocks Our Experts Are Trading Now
See More Electromed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Electromed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Electromed and other key companies, straight to your email.

About Electromed

Electromed (NYSE:ELMD) develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system for patients with compromised pulmonary functions, including bronchiectasis and cystic fibrosis, as well as neuromuscular conditions, such as cerebral palsy and amyotrophic lateral sclerosis; SmartVest SQL System; SmartVest Clearway System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment to create oscillatory pressure on the chest wall; and SmartVest Connect, a wireless technology that allows data connection between physicians and patients to track therapy performance and collaborate in treatment decisions. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products to hospitals, home health care centers, pulmonary rehabilitation centers, cystic fibrosis centers, neuromuscular clinics, and other clinics through distributors. It markets its products to physicians, health care providers, and directly to patients. Electromed, Inc. was incorporated in 1992 and is headquartered in New Prague, Minnesota.

View Electromed Profile

More Earnings Resources from MarketBeat